BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27634473)

  • 21. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
    Lu S; Taban M
    Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vogt-Koyanagi-Harada syndrome].
    Serna-Ojeda JC; Pedroza-Seres M
    Rev Fac Cien Med Univ Nac Cordoba; 2016; 73(2):132-3. PubMed ID: 27420148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PIGMENT AUTOAGGRESSION IN THE PATHOGENESIS OF VOGT-KOYANAGI-HARADA SYNDROME].
    KAHAN A; SZTANOJEVITS A; SZABADOS T; VASS Z; SZABO M
    Albrecht Von Graefes Arch Ophthalmol; 1964 Jul; 167():246-64. PubMed ID: 14250756
    [No Abstract]   [Full Text] [Related]  

  • 24. DETECTION OF CHOROIDAL FOLDS IN PATIENTS WITH VOGT-KOYANAGI-HARADA DISEASE BY RETROMODE SCANNING LASER OPHTHALMOSCOPY.
    Kinoshita T; Imaizumi H; Miyamoto H; Katome T; Mitamura Y
    Retin Cases Brief Rep; 2016; 10(2):160-4. PubMed ID: 26444520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical-Pathological Correlation of Vogt-Koyanagi-Harada Disease.
    Oellers P; Jaffe GJ; Proia AD
    JAMA Ophthalmol; 2016 Mar; 134(3):343-5. PubMed ID: 26746681
    [No Abstract]   [Full Text] [Related]  

  • 26. Vogt-Koyanagi-Harada syndrome with intracranial meningioma: an as yet unreported association.
    Kumar A; Chhabra MS; Prakash G; Kulkarni AD
    Can J Ophthalmol; 2005 Dec; 40(6):725-8. PubMed ID: 16518897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant prognostic factors for Vogt-Koyanagi-Harada disease in the early stage.
    Sheu SJ; Kou HK; Chen JF
    Kaohsiung J Med Sci; 2004 Mar; 20(3):97-105. PubMed ID: 15124893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
    Shin WB; Kim MK; Lee CS; Lee SC; Kim H
    Korean J Ophthalmol; 2015 Dec; 29(6):389-95. PubMed ID: 26635455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique clinical spectrum with distinguishing diagnostic features in Vogt-Koyanagi-Harada syndrome.
    Sultan M; Khan A; Habib SS; Abdulsalam D
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31888891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
    Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
    Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
    Khalifa Y; Loh AR; Acharya NR
    Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of the Vogt-Koyanagi-Harada syndrome].
    Peyresblanques J; Saint Val C; Collin JP
    Bull Soc Ophtalmol Fr; 1984; 84(6-7):827-30. PubMed ID: 6534621
    [No Abstract]   [Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada syndrome and pregnancy.
    Steahly LP
    Ann Ophthalmol; 1990 Feb; 22(2):59-62. PubMed ID: 2316953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
    Hirose S; Saito W; Yoshida K; Saito M; Dong Z; Namba K; Satoh H; Ohno S
    Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probable Vogt-Koyanagi-Harada's syndrome associated with tonic pupils.
    Narang S; Sood S; Malik A
    Nepal J Ophthalmol; 2010; 2(2):154-6. PubMed ID: 21505533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
    Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optic disc neovascularization in association with Vogt-Koyanagi-Harada syndrome.
    To KW; Nadel AJ; Brockhurst RJ
    Arch Ophthalmol; 1990 Jul; 108(7):918-9. PubMed ID: 1695093
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent Unilateral Vogt-Koyanagi-Harada Disease with Posterior Scleritis.
    Moon SY; Yoon WT; Park SP
    Korean J Ophthalmol; 2015 Oct; 29(5):352-4. PubMed ID: 26457043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.